Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Cataract HELP
Based on 7,590 articles published since 2008
||||

These are the 7590 published articles about Cataract that originated from Worldwide during 2008-2019.
 
+ Citations + Abstracts
Pages: 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · 11 · 12 · 13 · 14 · 15 · 16 · 17 · 18 · 19 · 20
1 Guideline The opinion of the Expert Group of the Polish Society of Ophthalmology on using nepafenac in the prevention of postoperative macular edema after cataract surgery in diabetic patients. 2016

Grabska-Liberek, Iwona / Bakunowicz-Łazarczyk, Alina / Malukiewicz, Grażyna / Misiuk-Hojło, Marta / Mrukwa-Kominek, Ewa / Romaniuk, Wanda / Romanowska-Dixon, Bożena / Jurowski, Piotr / Kęcik, Dariusz / Lubiński, Wojciech / Omulecki, Wojciech / Szaflik, Jerzy / Szaflik, Jacek P / Pietruszyńska, Marta / Karska-Basta, Izabella / Stafiej, Joanna / Gosławski, Wojciech. · ·Klin Oczna · Pubmed #29912514.

ABSTRACT: Nepafenac is an innovative non-steroidal anti-inflammatory drug used in ophthalmology for the prevention of macular edema after cataract surgery. Along with its anti-inflammatory effect, nepafenac has some unique properties which distinguish it from other non-steroidal anti-inflammatory drugs. It is a prodrug activated to amfenac after it penetrates through the corneal layers to the aqueous humour and the ciliary body. Having electrically neutral molecules of lipophilic properties, nepafenac does not accumulate in the cornea and does not cause its degeneration. Additionally, it quickly achieves higher concentrations in the aqueous humour as compared to other non-steroidal anti-inflammatory drugs. Nepafenac shows high selectivity and activity against COX-2 isoform, the key enzyme implicated in inducing inflammation, which is the main cause of macular edema. Furthermore, nepafenac has the unique scleral and suprachoroidal distribution pathways. Finally, its effect on the intraocular pressure is none to negligible. Nepafenac treatment should be initiated prior to cataract surgery and continued long enough to reduce the risk of late-onset macular edema. The Expert Group of the Polish Society of Ophthalmology consider using nepafenac in the prevention of post­operative macular edema in diabetic patients undergoing cataract surgery as expedient and reasonable. The proposed optimum pre- and postoperative treatment regimen can be modified for individualised therapy.

2 Guideline Screening for Impaired Visual Acuity in Older Adults: US Preventive Services Task Force Recommendation Statement. 2016

Anonymous1850860 / Siu, Albert L / Bibbins-Domingo, Kirsten / Grossman, David C / Baumann, Linda Ciofu / Davidson, Karina W / Ebell, Mark / García, Francisco A R / Gillman, Matthew / Herzstein, Jessica / Kemper, Alex R / Krist, Alex H / Kurth, Ann E / Owens, Douglas K / Phillips, William R / Phipps, Maureen G / Pignone, Michael P. ·Mount Sinai School of Medicine, New York2James J. Peters Veterans Affairs Medical Center, Bronx, New York. · University of California, San Francisco. · Group Health Research Institute, Seattle, Washington. · University of Wisconsin, Madison. · Columbia University, New York, New York. · University of Georgia, Athens. · Pima County Department of Health, Tucson, Arizona. · Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts. · Independent consultant, Washington, DC. · Duke University, Durham, North Carolina. · Fairfax Family Practice, Fairfax, Virginia13Virginia Commonwealth University, Richmond. · New York University, New York. · Veterans Affairs Palo Alto Health Care System, Palo Alto, California16Stanford University, Stanford, California. · University of Washington, Seattle. · Brown University, Providence, Rhode Island. · University of North Carolina, Chapel Hill. ·JAMA · Pubmed #26934260.

ABSTRACT: DESCRIPTION: Update of the US Preventive Services Task Force (USPSTF) recommendation on screening for impaired visual acuity in older adults. METHODS: The USPSTF reviewed the evidence on screening for visual acuity impairment associated with uncorrected refractive error, cataracts, and age-related macular degeneration among adults 65 years or older in the primary care setting; the benefits and harms of screening; the accuracy of screening; and the benefits and harms of treatment of early vision impairment due to uncorrected refractive error, cataracts, and age-related macular degeneration. POPULATION: This recommendation applies to asymptomatic adults 65 years or older who do not present to their primary care clinician with vision problems. RECOMMENDATION: The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for impaired visual acuity in older adults. (I statement).

3 Guideline [Narrow-band UVB therapy in psoriasis vulgaris: good practice guideline and recommendations of the French Society of Photodermatology]. 2010

Beani, J-C / Jeanmougin, M. ·Clinique universitaire de dermato-vénéréologie, photobiologie et allergologie, pôle pluridisciplinaire de médecine A.-Michallon, CHU de Grenoble, BP 217x, 38043 Grenoble cedex, France. JCBeani@chu-grenoble.fr ·Ann Dermatol Venereol · Pubmed #20110064.

ABSTRACT: BACKGROUND: Phototherapy, PUVA therapy and narrow-band UVB are recognised forms of first-line therapy for extensive and severe plaque psoriasis. Based on a systematic review of the medical literature, we propose a good practice guideline for the use of narrow-band UVB phototherapy in this indication. METHODS: We carried out a review of the literature published over the 20 years (1998 to 2009) in the online PubMed database. Our conclusions are based on the results of control studies or where these are absent, on a synthesis of the recommendations common practice approved by the experts of the French Society of Photodermatology. The levels of scientific proof given are based on the criteria defined by Sackett. RESULTS RECOMMENDATIONS: (1) Practical aspects. Irradiation cabins equipped with Philips TL01 tubes, either for monotherapy (42 tubes) or for combined therapy (21 UVB tubes and 21 UVA tubes), were to be certified (CE marking, ISO-DIN certification) and equipped with an accurate dosimetry system. Several valid and usable protocols exist. The indication was based on the severity and extent of the episode of psoriasis, the psychological consequences of the dermatosis, comparison of the benefit/risk ratios of the various available treatments, the ability of the patient to attend sessions (a vital factor in therapeutic compliance), the cumulative doses of UV from previous courses of treatment, and absence of contraindications, including the use of photosensitising medication. Informed consent was to be obtained from patients, who were given a validated information sheet (available at www.sfdermato.org). The study results and the value of maintenance therapy were not confirmed. (2) Adverse effects. The immediate adverse effects were generally of little consequence, with later effects alone posing problems. Because of the risk of induction of cataract, ocular protection must be used during sessions. In the absence of symptoms or known ocular disorder, prior ophthalmologic control is not considered necessary. The risk of skin cancer remains poorly defined, and this risk has not been clearly shown to be lower than with broad-spectrum UVB therapy or PUVA. The studies give no indication of the number of sessions after which therapy must be completely discontinued. In the absence of clear evaluation of oncogenic risk, it seems reasonable to set the maximum number of sessions of UVB TL01 phototherapy at 250 as with PUVA, and to include in this limit the total of all PUVA and TL01 phototherapy sessions for patients receiving both types of phototherapy (level of proof: B). In the absence of lesions requiring treatment in these areas, the face and male genital organs should be protected during treatment sessions. There is no currently available data concerning carcinogenic risk induced by TL01 in patients also on cyclosporine, methotrexate or biotherapies. In order to reduce risk and maintain patients' capacity to undergo further phototherapy sessions, we suggest (level of proof: A) the following measures: strict patient selection, use of combined synergistic therapies, annual examination of the skin and appendages of subjects receiving more than 150 phototherapy sessions, and the creation of nationally accessible patient phototherapy files. (3) Combined treatments. The purpose of such treatment is twofold: to reduce the risk of adverse effects while increasing the efficacy of TL01 phototherapy. Lesions should be sloughed before the start of phototherapy. Synergistic effects have been demonstrated for dermal corticosteroids and tazarotene, but such effects are less noticeable with topical vitamin D3 derivatives. If there are no contraindications to its prescription, we feel that acitretine has demonstrated efficacy in enhancing the effect of TL01 phototherapy. (4) Efficacy. Narrow-spectrum UVB phototherapy is considered highly effective in extensive psoriasis. At a rate of three sessions per week, it results in complete (or almost complete) eradication of lesions in 60 to 90 % of patients within 20 to 40 sessions (level of proof: A). However, the efficacy of this therapy varies according to plaque size and noticeably better results are obtained in guttate and nummular psoriasis than in psoriasis involving large plaques. CONCLUSION: Narrow-spectrum UVB phototherapy offers a good alternative to PUVA therapy since concomitant psoralen is not required, but there are few immediate adverse effects, there is less risk of drug-induced photosensitisation, and there is no need for skin or ocular photoprotection after sessions. We recommend this approach as the first-line phototherapy (level of proof: A) in children and adolescents, and in adults with extensive moderate psoriasis involving small superficial plaques. It may also be used in pregnant or breastfeeding women and in patients with renal or hepatic insufficiency. In addition, it is preferable for HIV-positive subjects (level of proof: C). However, PUVA therapy is preferable as first-line treatment in extensive severe psoriasis involving large thick plaques (level of proof: A) and in adults of phototypes IV to VI (level of proof: B); it should also be contemplated for psoriasis refractory to UVB TL01 (level of proof: B).

4 Guideline [Guidelines of clinical practice of the SERV (Spanish Retina and Vitreous Society): management of ocular complications of diabetes. Diabetic retinopathy and macular oedema]. 2009

Pareja-Ríos, A / Serrano-García, M A / Marrero-Saavedra, M D / Abraldes-López, V M / Reyes-Rodríguez, M A / Cabrera-López, F / López-Gálvez, M / Cardona-Guerra, P / Abreu-Reyes, P / Quijada-Fumero, E / Coronado-Toural, A / Gutiérrez-Sánchez, E / Gil-Hernández, M A / Valls-Quintana, P / Marín-Olmos, F / Navarro-Alemany, R. ·Hospital Universitario de Canarias, La Laguna, Tenerife, España. aparejar@gmail.com ·Arch Soc Esp Oftalmol · Pubmed #19809923.

ABSTRACT: OBJECTIVE: Diabetes mellitus is considered the most common cause of blindness in the working population of industrialized countries, with diabetic macular edema being the most common cause of decreased visual acuity and proliferative diabetic retinopathy (PDR) being responsible for the most severe visual deficits. We have therefore tried to establish a guide for clinical intervention whose purpose is to provide orientation on the treatment of diabetic retinopathy and its complications. This is necessary at a time when many treatment options have emerged whose role is not yet fully defined. METHOD: A group of expert retina specialists selected by the SERV (Vitreous-Retina Spanish Society) assessed the published results of different treatment options currently available, suggesting lines of action according to the degree of diabetic retinopathy present and the presence or absence of macular edema. RESULTS: PDR is primarily treated with pan-retinal photocoagulation. For clinically significant diabetic macular edema without signs of vitreomacular traction, the treatment of choice continues to be focal/grid photocoagulation. Similarly, retinovitreal surgery is indicated for both conditions. The use of antiangiogenic drugs was also analyzed but remains inconclusive. CONCLUSION: Laser therapy is effective in the management of diabetic retinopathy and diabetic macular edema. The role of antiangiogenics is not yet sufficiently defined.

5 Editorial Femtosecond laser-assisted cataract surgery: Back to the future. 2019

Mamalis, Nick. ·Salt Lake City, Utah, USA. ·J Cataract Refract Surg · Pubmed #30579513.

ABSTRACT: -- No abstract --

6 Editorial Tackling the cataract backlog - An initiative by the Maharashtra State, India. 2018

Lahane, Tatyarao P. ·Joint Director, Medical Education and Research, Maharashtra, India. ·Indian J Ophthalmol · Pubmed #30249820.

ABSTRACT: -- No abstract --

7 Editorial Risk factors for age-related cataract. 2018

Keel, Stuart / He, Mingguang. ·Centre for Eye Research Australia, University of Melbourne, Melbourne, Victoria, Australia. · State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China. ·Clin Exp Ophthalmol · Pubmed #29898261.

ABSTRACT: -- No abstract --

8 Editorial X-ray canary in the cath lab: Posterior cataracts. 2018

Ahmad, Tariq Ali / Gilchrist, IanC. ·Penn State University, College of Medicine, Heart & Vascular Institute, MS Hershey Medical Center, Hershey, Pennsylvania. ·Catheter Cardiovasc Interv · Pubmed #29532643.

ABSTRACT: Cataract formation in the posterior subcapsular region of the lens is a lesion highly specific to both high-dose acute radiation exposure and chronic low-dose exposure. Low-dose radiation may not manifest lens changes for several decades after initial exposure. Cardiac catheterization team members need to be educated on, and protected from, this form of radiation injury as its long latency period between exposure and physical damage may acutely reduce the sense of hazard amongst healthcare radiation workers.

9 Editorial Reducing the environmental impact of cataract surgery: Sustainability versus safety: A tradeoff? 2018

Mamalis, Nick. ·Salt Lake City, Utah, USA. ·J Cataract Refract Surg · Pubmed #29502595.

ABSTRACT: -- No abstract --

10 Editorial Preventing falls in older people with cataract - it is not just about surgery. 2018

Keay, Lisa / Palagyi, Anna. ·The George Institute for Global Health, UNSW Sydney, Australia. ·Ophthalmic Physiol Opt · Pubmed #29485206.

ABSTRACT: -- No abstract --

11 Editorial Rhegmatogenous Retinal Detachment after Pediatric Cataract Surgery. 2018

De la Huerta, Irina / Williams, George A. ·Royal Oak, Michigan. Electronic address: idelahuerta@arcpc.net. · Royal Oak, Michigan. ·Ophthalmology · Pubmed #29268866.

ABSTRACT: -- No abstract --

12 Editorial Cataract surgery and controversy: Susruta-Daviel-Kelman. 2017

Raju, V K / Raju, Leela V. ·Department of Ophthalmology, West Virginia University, Morgantown, WV, USA. · NYU Langone Health Eye Center, New York, USA. ·Indian J Ophthalmol · Pubmed #29208804.

ABSTRACT: -- No abstract --

13 Editorial Cataract surgery: The journey thus far. 2017

Sachdev, Mahipal. ·Chairman and Medical Director, Centre for Sight, B-5/24, Safdarjung Enclave, New Delhi - 110 029, India. ·Indian J Ophthalmol · Pubmed #29208803.

ABSTRACT: -- No abstract --

14 Editorial Eliminating cataract blindness: Are we on target? 2017

Honavar, Santosh G. ·Editor, Indian Journal of Ophthalmology, Editorial Office, Centre for Sight, Road No. 2, Banjara Hills, Hyderabad - 500 034, Telangana, India. ·Indian J Ophthalmol · Pubmed #29208802.

ABSTRACT: -- No abstract --

15 Editorial Management of bilateral cataracts when general anaesthesia is required: same-day or different-day surgery? 2017

Roberts, Timothy V / Li, Shawn. ·Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia. · Department of Ophthalmology, Royal North Shore Hospital, Sydney, New South Wales, Australia. · Vision Eye Institute, Sydney, New South Wales, Australia. · Department of Anaesthesia, Royal North Shore Hospital, Sydney, New South Wales, Australia. ·Clin Exp Ophthalmol · Pubmed #29148261.

ABSTRACT: -- No abstract --

16 Editorial Something Old (Trabeculectomy), Something New (Ab Interno Gelatin Microstent): Finally, a Marriage of Innovation and Outcome Data (without Concurrent Cataract Surgery)! 2017

Heuer, Dale K / Heatley, Gregg A. ·Milwaukee, Wisconsin. Electronic address: dheuer@mcw.edu. · Madison, Wisconsin. ·Ophthalmology · Pubmed #29055363.

ABSTRACT: -- No abstract --

17 Editorial Hypertension and cataract surgery under loco-regional anaesthesia: not to be ignored? 2017

Kumar, C M / Seet, E / Eke, T / Joshi, G P. ·Department of Anaesthesia, Khoo Teck Puat Hospital, Yishun Central 90, Singapore. · Department of Ophthalmology, Norfolk and Norwich University Hospitals, Norwich, UK. · Department of Anaesthesia, University of Texas Southwestern Medical Center, Dallas, TX, USA. ·Br J Anaesth · Pubmed #29028916.

ABSTRACT: -- No abstract --

18 Editorial Practice patterns in pediatric cataract management: Time for real world data. 2017

Nischal, Ken Kanwal. ·UPMC Eye Center, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA, USA. ·Indian J Ophthalmol · Pubmed #28905817.

ABSTRACT: -- No abstract --

19 Editorial Learning curve in femtosecond laser-assisted cataract surgery. 2017

Sachdev, Mahipal Singh. ·Centre for Sight, Safdarjung Enclave, New Delhi, India. ·Indian J Ophthalmol · Pubmed #28820147.

ABSTRACT: -- No abstract --

20 Editorial Does having children earlier help you see things more clearly? 2017

Luo, Zhonghui K / Wu, David M. ·Massachusetts Eye and Ear Infirmary, Boston, MA. ·Menopause · Pubmed #28697047.

ABSTRACT: -- No abstract --

21 Editorial Challenges with cataract surgery in pars planitis patients. 2017

Grzybowski, Andrzej / Kanclerz, Piotr / Pleyer, Uwe. ·Department of Ophthalmology, Poznan City Hospital, ul. Szwajcarska 3, 61-285, Poznan, Poland. ae.grzybowski@gmail.com. · Department of Ophthalmology, University of Warmia and Mazury, Olsztyn, Poland. ae.grzybowski@gmail.com. · Department of Ophthalmology, Medical University of Gdańsk, Gdańsk, Poland. · Department of Ophthalmology, Charité, University Medicine Berlin, Campus Virchow-Klinikum, Berlin, Germany. ·Graefes Arch Clin Exp Ophthalmol · Pubmed #28593425.

ABSTRACT: -- No abstract --

22 Editorial Nonarteritic Anterior Ischemic Optic Neuropathy and Intraocular Surgery. 2017

McCulley, Timothy J / Lam, Byron L / Feuer, William J. ·The Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland. Electronic address: tmccull5@jhmi.edu. · Bascom Palmer Eye Institute, University of Miami, Miami, Florida. ·Am J Ophthalmol · Pubmed #28108001.

ABSTRACT: -- No abstract --

23 Editorial Glucocorticoid withdrawal in polymyalgia rheumatica: the theory versus the practice. 2017

Yates, Max / Watts, Richard A / Swords, Francesca / MacGregor, Alexander J. ·Norwich Medical School, University of East Anglia, Norwich; and Department of Rheumatology, Norfolk and Norwich University Hospital, UK. m.yates@uea.ac.uk. · Department of Rheumatology, Ipswich Hospital, UK. · Department of Rheumatology and Deparment of Endocrinology, Norfolk and Norwich University Hospital, Norwich, UK. · Norwich Medical School, University of East Anglia, Norwich; and Department of Rheumatology, Norfolk and Norwich University Hospital, UK. ·Clin Exp Rheumatol · Pubmed #28079505.

ABSTRACT: -- No abstract --

24 Editorial Ocular trauma is an important cause of unilateral visual impairment worldwide. According to Nepal blindness survey (Brillinat et al, 1985), it accounted for 2.4% of blindness, and in another community based study (Upadhyay M et al, 2001), the prevalence of ocular trauma was observed to be 0.7%. The Bhaktapur Eye Study confirms that "corneal trauma leading to ulceration" is the second most common cause of blindness after cataract in Nepal. 2016

Pradhan, Eli. · ·Nepal J Ophthalmol · Pubmed #28478463.

ABSTRACT: Ocular trauma is an important cause of unilateral visual impairment worldwide. According to Nepal blindness survey (Brillinat et al, 1985), it accounted for 2.4% of blindness, and in another community based study (Upadhyay M et al, 2001), the prevalence of ocular trauma was observed to be 0.7%. The Bhaktapur Eye Study confirms that "corneal trauma leading to ulceration" is the second most common cause of blindness after cataract in Nepal.

25 Editorial Glycaemic control during cataract surgery under loco-regional anaesthesia: a growing problem and we are none the wiser. 2016

Kumar, C M / Seet, E / Eke, T / Dhatariya, K / Joshi, G P. ·Department of Anaesthesia, Khoo Teck Puat Hospital, Yishun Central 90, Singapore chandra.kumar2406@gmail.com. · Department of Anaesthesia, Khoo Teck Puat Hospital, Yishun Central 90, Singapore. · Department of Ophthalmology, Norfolk and Norwich University Hospitals, Norwich, UK. · Elsie Bertram Diabetes Centre Norfolk and Norwich University Hospitals NHS Foundation Trust, Colney Lane, Norwich, NR4 7UY. · University of Texas Southwestern Medical Center, Dallas, TX, USA. ·Br J Anaesth · Pubmed #27956666.

ABSTRACT: -- No abstract --

Next